The many microscopic organisms, or microbiome, that live in our gut play a big part in keeping us healthy, yet a breakdown in communication between them and the rest of the body can badly affect our health. The EU-funded META-BIOME project set out to understand the causes of this miscommunication. To understand this could allow for new treatments against many diseases, benefiting all citizens.

The EU-funded POTENT project has been developing a new type of drug delivery system for glioblastoma, an aggressive form of brain cancer. It can considerably improve treatment outcomes for patients and increase their life expectancy. Clinical trials could start in 2 to 4 years, a step closer to making the system available for the patients that could most benefit from it.